Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
Biogen’s stock increased by 1% on Thursday following a positive opinion from Europe’s pharmaceutical regulator regarding their Alzheimer’s disease drug ...
Tag: Biogens
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.